| Prostate carcinoma

Axumin vs Pylarify

Side-by-side clinical, coverage, and cost comparison for prostate carcinoma.
Deep comparison between: Axumin vs Pylarify with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.
Safety signalsPylarify has a higher rate of injection site reactions vs Axumin based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Pylarify but not Axumin, including UnitedHealthcare
Sign up to reveal the full AI analysis
Axumin
Pylarify
At A Glance
IV injection
Single dose
Amino acid PET radiotracer
IV injection
Single dose
PSMA inhibitor imaging agent
Indications
  • Prostate carcinoma
  • Prostate carcinoma
Dosing
Prostate carcinoma 370 MBq (10 mCi) intravenous bolus injection; begin PET imaging 3-5 minutes after administration; scan from mid-thigh to base of skull over approximately 20-30 minutes.
Prostate carcinoma 333 MBq (9 mCi) as a single bolus IV injection; initiate imaging approximately 60 minutes after administration; patient should void immediately prior to image acquisition.
Contraindications
—
—
Adverse Reactions
Most common (<=1%) injection site pain, injection site erythema, dysgeusia
Most common (>0.5%) Headache, dysgeusia, fatigue
Serious Hypersensitivity reaction
Pharmacology
Fluciclovine F 18 is a synthetic amino acid analog transported across mammalian cell membranes by amino acid transporters (LAT-1 and ASCT2) that are upregulated in prostate cancer cells, resulting in greater uptake in prostate cancer cells compared with surrounding normal tissues.
Piflufolastat F-18 is a PSMA-targeted radioligand that binds to PSMA-expressing cells, including malignant prostate cancer cells that typically overexpress PSMA; fluorine-18 is a positron-emitting radionuclide that enables PET imaging.
View Full FDA Information
View full FDA information
View full FDA information
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
No coverage data available for Axumin.
No coverage data available for Pylarify.
UnitedHealthcare
No coverage data available for Axumin.
No coverage data available for Pylarify.
Humana
No coverage data available for Axumin.
No coverage data available for Pylarify.
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Axumin.
No savings programs available for Pylarify.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Next Steps for Your Patient
AxuminView full Axumin profile
PylarifyView full Pylarify profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.